Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
BIORCHESTRA Announces Significant Progress in Studies of BMD-001 Drug Program
BIORCHESTRA, a biotherapeutics company focused on rare and degenerative diseases within the Central Nervous System […]
Forge Biologics Receives Qualified Person (QP) Declaration to Manufacture AAV Gene Therapies to Support European Clinical Programs
Forge Biologics, a leading manufacturer of genetic medicines, today announced that its manufacturing facility has […]
Bridge Biotherapeutics Receives FDA Authorization to Proceed with the First-in-Human Study of BBT-207
Bridge Biotherapeutics, a clinical-stage biotech company based in South Korea and Cambridge that is advancing novel drugs for […]
Daewoong Pharmaceutical Announce Publication of Phase 3 Study of 'Envlo', a New Treatment for Diabetes
The research results of a Daewoong Pharmaceutical SGLT-2 inhibitor new drug for diabetes, ‘Envlo’, have been […]
MaaT Pharma Announces U.S. FDA Lifts Clinical Hold on Phase 3 Investigational New Drug Application for MaaT013 in Patients with Acute Graft-versus-Host Disease
MaaT Pharma, a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem […]
CymaBay Therapeutics Announces Publication of Results From the ENHANCE, Phase 3 Study of Seladelpar in Patients with Primary Biliary Cholangitis (PBC)
CymaBay Therapeutics, a biopharmaceutical company focused on developing and providing access to innovative therapies for […]
Verana Health Announces the Qdata Parkinson's Disease Module at 2023 AAN Annual Meeting
Verana Health, a digital health company elevating quality in real-world data (RWD), has announced it’s […]
Life Biosciences Presents Groundbreaking Data at ARVO Demonstrating Restoration of Visual Function in Nonhuman Primates
Life Biosciences (Life Bio), a biotechnology company advancing innovative cellular rejuvenation technologies to reverse diseases […]
CPC Launches Biopharma's Largest Aseptic Connectors, AseptiQuik W Series
CPC (Colder Products Company), part of Dover and a leading manufacturer of connection technologies used […]
SciSparc and Clearmind Collaboration Strengthens IP Portfolio with Patent Application in the U.S. for Treatment of Depression
SciSparc, a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more